Literature DB >> 19375605

Electrophysiologic, morphologic, and serologic features of chronic unexplained nausea and vomiting: lessons learned from 121 consecutive patients.

Thomas L Abell1, Babajide Familoni, Guy Voeller, Robert Werkman, Pat Dean, Bradford Waters, David Smalley, J R Salameh.   

Abstract

BACKGROUND: Despite substantive morbidity, unexplained nausea and vomiting has not been evaluated in a systematic manner via surgically obtained biopsies and direct electrophysiology of the gut, and this information has not been correlated with serologic information. We investigated consecutive patients with unexplained and refractory chronic nausea and vomiting to define the presence of morphologic, physiologic, and/or serologic abnormalities.
METHODS: In all, 101 of 121 consecutive patients who experienced chronic nausea and vomiting of unknown etiology evaluated in 1 tertiary referral center over a 10-year period were profiled qualitatively by full-thickness small bowel biopsies with hematoxylin and eosin (H&E) and Smith's Silver stains, quantitatively by intraoperative gastric electrophysiology, and semiquantitatively, when it became available, by serum autoimmune Western blot analysis.
RESULTS: Overall, 79 of 101 patients had abnormal full-thickness biopsy (70 neuropathies and 9 myopathies) and frequent serum autoimmune abnormalities (mean score = 13.2, normal < 3.0). In addition, 96 of 101 patients had abnormal frequency and/or uncoupling on gastric electrophysiology. Patients with small-intestinal myopathy showed a diversity of diagnoses; some patients with neuropathy had abdominal pain that correlated with autoimmune scores on Western blot.
CONCLUSION: Patients with refractory and unexplained nausea and vomiting have a high incidence of both small bowel morphologic abnormalities (primarily neuropathies) and gastric electrophysiologic abnormalities, which are associated commonly with serologic autoimmune activation. Similar histomorphologic, physiologic, and serologic measures should be considered in the diagnostic evaluation of any patient with refractory or unexplained nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375605     DOI: 10.1016/j.surg.2008.12.006

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities.

Authors:  Thomas L Abell; Archana Kedar; Abigail Stocker; Karen Beatty; Lindsay McElmurray; Michael Hughes; Hani Rashed; William Kennedy; Gwen Wendelschafer-Crabb; Xiu Yang; Mostafa Fraig; Leila Gobejishvili; Endashaw Omer; Ed Miller; Michael Griswold; Christina Pinkston
Journal:  Dig Dis Sci       Date:  2020-04-23       Impact factor: 3.199

2.  Characteristics of myoelectrical activities along the small intestine and their responses to test meals of different glycemic index in rats.

Authors:  Yi Liu; Feng Ye; Sujuan Zhang; Shiying Li; Jiande Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

Review 3.  What are the important subsets of gastroparesis?

Authors:  M Camilleri; M Grover; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

4.  A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis.

Authors:  Thomas L Abell; William D Johnson; Archana Kedar; J Matthew Runnels; Janelle Thompson; Ernest S Weeks; Anil Minocha; Michael E Griswold
Journal:  Gastrointest Endosc       Date:  2011-09       Impact factor: 9.427

5.  Gastric electrical stimulation optimized to inhibit gastric motility reduces food intake in dogs.

Authors:  Geng-Qing Song; Hongbing Zhu; Yong Lei; Charlene Yuan; Warren Starkebaum; Jieyun Yin; Jiande D Z Chen
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

6.  Recent progress in gastric arrhythmia: pathophysiology, clinical significance and future horizons.

Authors:  Gregory O'Grady; Tim H-H Wang; Peng Du; Tim Angeli; Wim J E P Lammers; Leo K Cheng
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-10       Impact factor: 2.557

7.  Clinical guideline: management of gastroparesis.

Authors:  Michael Camilleri; Henry P Parkman; Mehnaz A Shafi; Thomas L Abell; Lauren Gerson
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

8.  Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.

Authors:  W L Hasler; L A Wilson; H P Parkman; K L Koch; T L Abell; L Nguyen; P J Pasricha; W J Snape; R W McCallum; I Sarosiek; G Farrugia; J Calles; L Lee; J Tonascia; A Unalp-Arida; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2013-02-17       Impact factor: 3.598

9.  Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting.

Authors:  Timothy R Angeli; Leo K Cheng; Peng Du; Tim Hsu-Han Wang; Cheryl E Bernard; Maria-Giuliana Vannucchi; Maria Simonetta Faussone-Pellegrini; Christopher Lahr; Ryash Vather; John A Windsor; Gianrico Farrugia; Thomas L Abell; Gregory O'Grady
Journal:  Gastroenterology       Date:  2015-04-08       Impact factor: 22.682

10.  Mini-laparotomy with Adjunctive Care versus Laparoscopy for Placement of Gastric Electrical Stimulation.

Authors:  Alison Smith; Robert Cacchione; Ed Miller; Lindsay McElmurray; Robert Allen; Abigail Stocker; Thomas L Abell; Michael G Hughes
Journal:  Am Surg       Date:  2016-04       Impact factor: 0.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.